Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Related Articles

Just Published

10 hours ago

Timeline of a mega-merger: The origins of Omnicom ...

See the full timeline of advertising's new powerhouse merger here.

17 hours ago

40 Under 40 2024: Neel Chhaya, DDB Group

A people-first leader, Chhaya has been instrumental in fuelling DDB Group’s client growth, reshaping service delivery, and fostering a culture of inclusivity.

17 hours ago

Leo Burnett and OMD lead Agency of the Year APAC awards

Publicis Groupe led in creativity, PR, and culture, with OMD dominating media.

19 hours ago

Special Group dominates at ANZ's Agency of the Year

Special and Howatson+Company were the only agencies to win more than one Gold on the night, but The Monkeys scooped the coveted Gold for Australia Creative Agency of the Year.